Gratchev A, Kzhyshkowska J, Duperrier K, Utikal J, Velten F W, Goerdt S
Department of Dermatology, University Medical Centre Mannheim, Ruprecht-Karls University of Heidelberg, Mannheim, Germany.
Scand J Immunol. 2004 Sep;60(3):233-7. doi: 10.1111/j.0300-9475.2004.01443.x.
Interleukin-17E (IL-17E) (IL-25) is a recently identified cytokine capable to induce Th2-associated cytokine production (IL-5 and IL-13) and T helper 2 (Th2)-type pathologies in animal models. The IL-17E-responsive cell population in vivo was described to be a further uncharacterized non-T-, non-B-splenic accessory cell. Despite the identification of IL-17BR as the receptor for IL-17E, the cell population expressing IL-17BR has hitherto not been identified. Here, we show that human monocyte-derived Th2-skewed antigen-presenting cells (APC2) express membrane-bound and soluble forms of IL-17BR on the mRNA and protein level upon stimulation with IL-4, IL-10, IL-13 or transforming growth factor-betain vitro. These results indicate that IL-17BR-expressing APC2s may mediate the development of the IL-17E-mediated immunological reaction patterns observed in vivo.
白细胞介素-17E(IL-17E)(IL-25)是一种最近发现的细胞因子,能够在动物模型中诱导Th2相关细胞因子的产生(IL-5和IL-13)以及T辅助2(Th2)型病理变化。体内对IL-17E有反应的细胞群体被描述为一种尚未进一步明确的非T、非B脾辅助细胞。尽管已确定IL-17BR是IL-17E的受体,但迄今尚未鉴定出表达IL-17BR的细胞群体。在此,我们表明,在体外经IL-4、IL-10、IL-13或转化生长因子-β刺激后,人单核细胞衍生的Th2偏向性抗原呈递细胞(APC2)在mRNA和蛋白质水平上表达膜结合型和可溶性形式的IL-17BR。这些结果表明,表达IL-17BR的APC2可能介导了体内观察到的IL-17E介导的免疫反应模式的发展。